ATYPICAL; MYCOBACTERIUM, PULMONARY, TUBERCULOUS

Clinical trials for ATYPICAL; MYCOBACTERIUM, PULMONARY, TUBERCULOUS explained in plain language.

Never miss a new study

Get alerted when new ATYPICAL; MYCOBACTERIUM, PULMONARY, TUBERCULOUS trials appear

Sign up with your email to follow new studies for ATYPICAL; MYCOBACTERIUM, PULMONARY, TUBERCULOUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Doctors test new drug combo to fight stubborn lung bug

Disease control Completed

This study tested which of two different three-drug antibiotic combinations was better at clearing a specific type of hard-to-treat lung infection. It involved 92 adults in France who had a confirmed Mycobacterium xenopi infection. The goal was to see which regimen helped patient…

Matched conditions: ATYPICAL; MYCOBACTERIUM, PULMONARY, TUBERCULOUS

Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

ATYPICAL; MYCOBACTERIUM, PULMONARY, TUBERCULOUS

Get alerted when new ATYPICAL; MYCOBACTERIUM, PULMONARY, TUBERCULOUS trials appear

Doctors test new drug combo to fight stubborn lung bug